Cargando…
Astragaloside in cancer chemoprevention and therapy
Tumor chemoprevention and treatment are two approaches aimed at improving the survival of patients with cancers. An ideal anti-tumor drug is that which not only kills tumor cells but also alleviates tumor-causing risk factors, such as precancerous lesions, and prevents tumor recurrence. Chinese herb...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278710/ https://www.ncbi.nlm.nih.gov/pubmed/37075760 http://dx.doi.org/10.1097/CM9.0000000000002661 |
_version_ | 1785060534433873920 |
---|---|
author | Wang, Yaning Zhang, Zhuo Cheng, Zhaohua Xie, Wei Qin, Hanjiao Sheng, Jiyao |
author_facet | Wang, Yaning Zhang, Zhuo Cheng, Zhaohua Xie, Wei Qin, Hanjiao Sheng, Jiyao |
author_sort | Wang, Yaning |
collection | PubMed |
description | Tumor chemoprevention and treatment are two approaches aimed at improving the survival of patients with cancers. An ideal anti-tumor drug is that which not only kills tumor cells but also alleviates tumor-causing risk factors, such as precancerous lesions, and prevents tumor recurrence. Chinese herbal monomers are considered to be ideal treatment agents due to their multi-target effects. Astragaloside has been shown to possess tumor chemoprevention, direct anti-tumor, and chemotherapeutic drug sensitization effects. In this paper, we review the effects of astragaloside on tumor prevention and treatment and provide directions for further research. |
format | Online Article Text |
id | pubmed-10278710 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-102787102023-06-20 Astragaloside in cancer chemoprevention and therapy Wang, Yaning Zhang, Zhuo Cheng, Zhaohua Xie, Wei Qin, Hanjiao Sheng, Jiyao Chin Med J (Engl) Review Article Tumor chemoprevention and treatment are two approaches aimed at improving the survival of patients with cancers. An ideal anti-tumor drug is that which not only kills tumor cells but also alleviates tumor-causing risk factors, such as precancerous lesions, and prevents tumor recurrence. Chinese herbal monomers are considered to be ideal treatment agents due to their multi-target effects. Astragaloside has been shown to possess tumor chemoprevention, direct anti-tumor, and chemotherapeutic drug sensitization effects. In this paper, we review the effects of astragaloside on tumor prevention and treatment and provide directions for further research. Lippincott Williams & Wilkins 2023-04-18 2023-05-20 /pmc/articles/PMC10278710/ /pubmed/37075760 http://dx.doi.org/10.1097/CM9.0000000000002661 Text en Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | Review Article Wang, Yaning Zhang, Zhuo Cheng, Zhaohua Xie, Wei Qin, Hanjiao Sheng, Jiyao Astragaloside in cancer chemoprevention and therapy |
title | Astragaloside in cancer chemoprevention and therapy |
title_full | Astragaloside in cancer chemoprevention and therapy |
title_fullStr | Astragaloside in cancer chemoprevention and therapy |
title_full_unstemmed | Astragaloside in cancer chemoprevention and therapy |
title_short | Astragaloside in cancer chemoprevention and therapy |
title_sort | astragaloside in cancer chemoprevention and therapy |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278710/ https://www.ncbi.nlm.nih.gov/pubmed/37075760 http://dx.doi.org/10.1097/CM9.0000000000002661 |
work_keys_str_mv | AT wangyaning astragalosideincancerchemopreventionandtherapy AT zhangzhuo astragalosideincancerchemopreventionandtherapy AT chengzhaohua astragalosideincancerchemopreventionandtherapy AT xiewei astragalosideincancerchemopreventionandtherapy AT qinhanjiao astragalosideincancerchemopreventionandtherapy AT shengjiyao astragalosideincancerchemopreventionandtherapy |